BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Denver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20220313T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20221106T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20230312T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20231105T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20240310T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20241103T080000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231112
DTEND;VALUE=DATE:20231116
DTSTAMP:20230905T165451Z
CREATED:20230905T165351Z
LAST-MODIFIED:20230905T165451Z
UID:59051-1699747200-1700092799@globalbiodefense.com
SUMMARY:APHA 2023 Annual Meeting & Expo
DESCRIPTION:The 2023 Annual Meeting of the American Public Health Association (APHA 2023) will be held 12-15 November in Atlanta\, Georgia. \nThis year’s premier public health event will be held both in-person and via live and recorded on-demand virtual sessions. \nTopics and sessions highlighted by include: \n\nBuilding partnerships to solve public health emergencies\nAssessing the performance of posterior oral and nasal swabs in a point-of-care tests for SARS-CoV-2\nSupporting equitable public health solutions with saliva-based testing – an innovative\, low-cost\, and scalable testing methodology\nRisk of invasive bacterial infections in under-immunized febrile patients between 2 and 36 months old presenting to the emergency department\nA retrospective geospatial study of chronic wasting disease in Kansas\nQMRA as a tool for probabilistic risk assessment of legionella in drinking and building water distribution systems\nHuman pathogenic bacteria in stream sediments: Teaching beginners the microbiological and bioinformatic methods of public health pathogenomics\nEvaluation for efficacy of field point-of-care malaria diagnostic methods in Ethiopia\nPrevalence and factors associated with HIV testing among sexually experienced high school students in U.S.A.\nLegionella in the Built Environment:  Emerging Research\, Practices\, and Policies\nApplication of systems thinking to investigating and managing legionella risk in cooling towers: Examples from the city and state of New York\nAn integrated vector management program for the prevention and control of the Aedes aegypti mosquito in Puerto Rico\nGut feelings: Investigating diarrhea etiology in low-and middle-income country (LMIC) children\nInsurance coverage and hepatitis b vaccination among Chinese American adults: An analysis of national health interview survey data\nDrug-resistant tuberculosis: A reflection on the development of contemporary treatment policy\nIdentifying the behavioral and social drivers for under-immunized or zero-dose vaccination of children in urban communities of Kathmandu\, Nepal\nDigital health literacy assessment: Insights into the challenges of health informatics in Ukraine\nFactors associated with COVID-19 health misinformation and vaccine hesitancy among hispanic adults in southern California\nPerceived impact of COVID-19 on parental vaccine hesitancy and pediatrician vaccination recommendation behavior\nEffect of positive emotions on vaccine hesitancy: An experimental study with vaccine-hesitant individuals\nUnderstanding geographical information systems (GIS) and its public health informatics applications\nThreats to public health workers\nHarnessing AI for public health preparedness\nLeveraging data to increase supply chain resilience\n\nPlease visit APHA’s Annual Meeting & Expo website to register.
URL:https://globalbiodefense.com/event/apha-2023-annual-meeting-expo/
LOCATION:Georgia World Congress Center\, 285 Andrew Young International Blvd NW\, Atlanta\, GA\, 30313\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231114
DTEND;VALUE=DATE:20231119
DTSTAMP:20231028T204037Z
CREATED:20230422T182706Z
LAST-MODIFIED:20231028T204037Z
UID:57061-1699920000-1700351999@globalbiodefense.com
SUMMARY:AMP 2023 Annual Meeting & Expo
DESCRIPTION:The Association for Molecular Pathology (AMP) 2023 Annual Meeting & Expo will be held 14-18 November 2023 in Salt Lake City\, Utah. \nAMP is the leading organization in the field of molecular diagnostics\, and the annual meeting is widely considered the “premier gathering” of molecular professionals. With more than 200 exhibiting companies\, 60 educational sessions\, nearly 400 poster presentations\, and 2\,900+ attendees\, the AMP Annual Meeting & Expo is not to be missed. \nExplore how cutting-edge technology and developments in molecular testing continue to have a major and direct impact on patient care. \nThe event begins November 14 with a Short Course Day\, November 15 is the Corporate Workshop Day. This day features 80+ hours of industry sponsored scientific content. This event is free for Annual Meeting attendees and the local healthcare and scientific communities. November 16-18 contains the Scientific Program. \nPlease visit the AMP 2023 Annual Meeting website for more information and to register.
URL:https://globalbiodefense.com/event/amp-2023-association-molecular-pathology/
LOCATION:Salt Palace Convention Center\, 100 S W Temple St\, Salt Lake City\, UT\, 84101\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240310
DTEND;VALUE=DATE:20240315
DTSTAMP:20240112T174003Z
CREATED:20240112T174003Z
LAST-MODIFIED:20240112T174003Z
UID:59619-1710028800-1710460799@globalbiodefense.com
SUMMARY:CDC International Symposium on Biosafety 2024
DESCRIPTION:The 18th CDC International Symposium on Biosafety – Modernizing Biosafety Operations and Practices – will be held 10-14 March 2024 in Atlanta\, Georgia. \nThe symposium offers a showcase of the latest advancements in biosafety research\, interactive workshops to gain practical insights on applications\, expert insight on design and operation of biocontainment and animal facilities\, and behind-the-scene tours of the Emory Primate Center Field Research Station and CDC’s Emergency Operations Center Laboratory Training Facility. \nHighlighted conference topics and sessions include: \n\nModern Lab Design: A Success Story\nQuestions to Consider When Designing ABSL-3 Facilities\nABSL-3 Case Study\nImplementing ISO 35001\nWaste Management in Animal Facilities\nLatest in Biosafety Research\nPanel: Hiring\, Retention\, Worker Shortage\nAI’s Role in Biosafety Training\nSpaceflight Microbiology: Mitigating Health and Habitat Risks While Living and Working in Space\nPathogens of the Future\n\nPre-conference classes will be offered for all levels: \n\nBiosafety 101\nEstablishing Biosafety Levels in the Field\nReviewing Past Exposures to Improve Biosafety\nNavigating the Integration of Biosafety\, Biosecurity\, and Emergency Management\nRisky Business: Animal Biosafety Assessments\n\nPoster Abstracts are being accepted until 15 February 2024. \nPlease visit the Eagleson Institute’s CDC International Symposium on Biosafety page to register for this event.
URL:https://globalbiodefense.com/event/cdc-international-symposium-on-biosafety-2024/
LOCATION:Crown Plaza Ravinia\, 4355 Ashford Dunwoody Rd\, Atlanta\, GA\, 30346\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240312
DTEND;VALUE=DATE:20240318
DTSTAMP:20240106T184627Z
CREATED:20230422T184308Z
LAST-MODIFIED:20240106T184627Z
UID:57065-1710201600-1710719999@globalbiodefense.com
SUMMARY:2024 Fungal Genetics Conference
DESCRIPTION:The 2024 Fungal Genetics Conference\, the premier meeting for fungal genetics researchers\, will be held 12-17 March 2024 in Pacific Grove\, California \nThe Fungal Genetics Conference is the premier meeting for the international community of fungal geneticists. The conference features cutting-edge research spanning a diverse array of topics\, including comparative and functional genomics\, gene regulation\, cell biology\, biochemistry and metabolism\, population and evolutionary genetics\, host-pathogen interactions\, genetics education\, and more. \nThis is considered by many to be the pre-eminent meeting in this area and promotes interaction between researchers interested in medical pathogens\, plant pathogens\, saprobic fungi and symbiotic fungi. \n\nHighlighted topics and sessions include:\nFunctional genomics illuminates foundational biology and evolution\nNew technologies to understand and control antifungal resistance\nMultilevel regulatory circuits to understand fungal metabolism\nUnderneath\, within\, and around: pathogens and symbionts\nGenetic control of primary and secondary metabolism\nFungi at the cutting edge – microfluidics and other new tools\nMachine Learning in Fungal Genetics\nExperimental evolution with fungi\nInteractions of fungi with the biosphere\nMorphogenesis at multiple scales\nHorizontal gene transfer\, meiotic drive\, and related phenomena\nBiofilms\, biocontrol\, and disease prevention by genome engineering\nUnderstanding fungal pathogenesis by genomics\nSignaling in the gas phase\nPhase separation and sequestration\n\nA virtual attendance option is planned in addition to the in-person meeting. Virtual participant registration fees for full-time residents of any country with low- and middle-income economies will be waived. \nPlease visit the Genetics Society of America 2024 Fungal Genetics Conference website for more the latest information and to register.
URL:https://globalbiodefense.com/event/2024-fungal-genetics-conference/
LOCATION:Asilomar Conference Grounds\, 800 Asilomar Ave\, Pacific Grove\, CA\, 93950\, United States
CATEGORIES:Conference
ORGANIZER;CN="Genetics Society of America":MAILTO:society@genetics-gsa.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241114T093000
DTEND;TZID=America/New_York:20241114T170000
DTSTAMP:20241107T191142Z
CREATED:20241107T191142Z
LAST-MODIFIED:20241107T191142Z
UID:61954-1731576600-1731603600@globalbiodefense.com
SUMMARY:Integration Site Analysis During Long Term Follow-Up for Gene Therapies with Integrating Viral Vectors
DESCRIPTION:The FDA’s Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products (OTP) is hosting a virtual scientific public workshop on the clinical use of integration site analysis (ISA) during long term follow-up following administration of gene therapies with integrating viral vectors. \nIn this workshop\, FDA will convene a panel of external experts to discuss the risk of insertional mutagenesis and best practices for ISA method design\, data analysis\, and clinical interpretation. The workshop participants will include research scientists with experience in vector design and ISA\, as well as clinician-scientists with expertise in clinical interpretation of ISA data. \nFocus for this Workshop\nAs of 2024\, twelve approved and hundreds of investigational cell-based gene therapies use integrating viral vectors. While stable integration may have considerable therapeutic benefits\, integration into genomic DNA can alter host gene expression and may contribute to secondary malignancies via insertional mutagenesis. Additionally\, the choice of vector (e.g.\, lentivirus versus gammaretrovirus) and cell substrate (e.g.\, T cells versus CD34+ cells) may also contribute to this risk. \nISA is the established approach to identify vector insertion sites. However\, ISA method design and data interpretation are highly complex and product-specific. Moreover\, ISA methods may be costly and challenging to perform. There is a critical need to understand the best practices for product design and ISA method design\, execution\, and interpretation to facilitate efficient evaluation of complex gene therapy products and protect the public from potential serious adverse events. \nThis workshop will include discussions on the following topics: \n\nEffects of Cell Substrate and Vector Design on the Risk of Vector Insertion-Related Adverse Events\nISA Methodology\, Assay Design\, and Analytical Capabilities\nISA Analysis\, Quality Control\, and Data Reporting\nClinical Follow-Up for Integrating Viral Vectors\nUsing ISA to Inform Clinical Decisions\n\nFor current guidance on the role of ISA in clinical follow-up\, please refer to section V.F “Special Considerations Regarding Integrating Vectors” of the FDA Guidance for Industry “Long Term Follow-Up After Administration of Human Gene Therapy Products” dated January 2020 (https://www.fda.gov/media/113768/download). \n Registration is required.
URL:https://globalbiodefense.com/event/integration-site-analysis-during-long-term-follow-up-for-gene-therapies-with-integrating-viral-vectors/
CATEGORIES:Conference,Government Hosted
LOCATION:
END:VEVENT
END:VCALENDAR